Passage Bio to Participate in Upcoming Investor Conferences
A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event.
Logitech to Participate in Upcoming Investor Conferences
A link to the Morgan Stanley TMT Conference webcast will be available on the Logitech corporate website at Webcast replays will be archived and will remain available for one year. Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working,
Alto Neuroscience to Participate in Upcoming Investor Conferences
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that m
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
Live webcasts for both events will be available on the Rapid Micro Biosystems investor relations website at and can be accessed here. The webcast will be archived and available for replay after the event.
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation at the following investor conferences: Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel,
Hosted on MSN25d
Passage Bio shares transition to Nasdaq Capital Market
Passage Bio has been granted an additional 180 days, until July 28, 2025, to meet the minimum bid price requirement. During this period, the company's closing bid price must reach or exceed $1.00 ...
Nasdaq1mon
Passage Bio Reports Positive Interim Data For PBFT02 In FTD-GRN
(RTTNews) - Passage Bio (PASG), a clinical-stage genetic medicines ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Passage Bio will again trim workforce in latest cost-cutting move
Passage Bio is outsourcing future analytical testing services in a cost-cutting move that will further cut its workforce, a ...
Passage Bio CFO sells shares worth $1,685
Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed a series of stock ...
Nasdaq2mon
Passage Bio, Inc. Common Stock (PASG) Institutional Holdings
Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information.
Investing6d
Passage Bio Inc (PASG)
Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed... Passage ...